NO303734B1 - Triazolyltiometyltiocefalosporin-hydroklorid, dets krystallinske hydrat samt farmasaytisk preparat inneholdende dette - Google Patents

Triazolyltiometyltiocefalosporin-hydroklorid, dets krystallinske hydrat samt farmasaytisk preparat inneholdende dette

Info

Publication number: NO303734B1
Authority: NO; Norway
Prior art keywords: crystalline hydrate; hydrochloride; triazolylthiomethylthiocephalosporin; pharmaceutical composition; composition containing
Prior art date: 1992-07-31

Application number

NO932745A

Other languages

English (en)

Norwegian (no)

Other versions

NO932745D0 (no

NO932745L (no

Inventor

Hisanori Takahashi

Yutaka Ide

Original Assignee

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-31

Filing date

1993-07-30

Publication date

1998-08-24

1993-07-30 Application filed by Shionogi & Co filed Critical Shionogi & Co

1993-07-30 Publication of NO932745D0 publication Critical patent/NO932745D0/no

1994-02-01 Publication of NO932745L publication Critical patent/NO932745L/no

1998-08-24 Publication of NO303734B1 publication Critical patent/NO303734B1/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO932745A 1992-07-31 1993-07-30 Triazolyltiometyltiocefalosporin-hydroklorid, dets krystallinske hydrat samt farmasaytisk preparat inneholdende dette NO303734B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP20496592		1992-07-31

Publications (3)

Publication Number	Publication Date
NO932745D0 NO932745D0 (no)	1993-07-30
NO932745L NO932745L (no)	1994-02-01
NO303734B1 true NO303734B1 (no)	1998-08-24

Family

ID=16499234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO932745A NO303734B1 (no)	1992-07-31	1993-07-30	Triazolyltiometyltiocefalosporin-hydroklorid, dets krystallinske hydrat samt farmasaytisk preparat inneholdende dette

Country Status (23)

Country	Link
US (1)	US5407929A (it)
EP (1)	EP0581552B1 (it)
KR (1)	KR100245938B1 (it)
CN (1)	CN1037683C (it)
AT (1)	ATE165360T1 (it)
AU (1)	AU657866B2 (it)
BR (1)	BR9303235A (it)
CA (1)	CA2101502A1 (it)
DE (1)	DE69318077T2 (it)
ES (1)	ES2115725T3 (it)
FI (1)	FI933391L (it)
GR (1)	GR3026699T3 (it)
HU (1)	HU219637B (it)
IL (1)	IL106516A (it)
MX (1)	MX9304611A (it)
NO (1)	NO303734B1 (it)
NZ (1)	NZ248285A (it)
PH (1)	PH30109A (it)
PL (2)	PL172835B1 (it)
RU (1)	RU2118959C1 (it)
TW (1)	TW307769B (it)
UA (1)	UA37181C2 (it)
ZA (1)	ZA935529B (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EE05643B1 (et) *	2001-02-24	2013-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
AT413282B (de) *	2002-02-01	2006-01-15	Sandoz Ag	Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) *	2002-03-21	2003-09-29	주식회사 엘지생명과학	신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en)	2002-11-12	2004-04-27	Kansas State University Research Foundation	Compounds affecting cholesterol absorption
CN101219992B (zh)	2003-02-12	2011-08-31	日产化学工业株式会社	匹伐他汀钙的晶形
JP5230934B2 (ja)	2003-03-27	2013-07-10	バジリアファルマスーチカアーゲー	結晶形態のセファロスポリン
US7501426B2 (en) *	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) *	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
CN102838599A (zh)	2006-05-04	2012-12-26	贝林格尔.英格海姆国际有限公司	多晶型
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
AU2008290582B2 (en) *	2007-08-17	2014-08-14	Boehringer Ingelheim International Gmbh	Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
KR20200118243A (ko)	2008-08-06	2020-10-14	베링거 인겔하임 인터내셔날 게엠베하	메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX370599B (es) *	2008-08-15	2019-12-18	Boehringer Ingelheim Int	Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
BRPI0919288A2 (pt)	2008-09-10	2015-12-15	Boehring Ingelheim Internat Gmbh	teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EA022310B1 (ru)	2008-12-23	2015-12-30	Бёрингер Ингельхайм Интернациональ Гмбх	Солевые формы органического соединения
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
NZ599298A (en)	2009-11-27	2014-11-28	Boehringer Ingelheim Int	Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011138421A1 (en)	2010-05-05	2011-11-10	Boehringer Ingelheim International Gmbh	Combination therapy
NZ603319A (en)	2010-06-24	2015-04-24	Boehringer Ingelheim Int	Diabetes therapy
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en)	2011-07-15	2020-06-23	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
US20130303554A1 (en)	2012-05-14	2013-11-14	Boehringer Ingelheim International Gmbh	Use of a dpp-4 inhibitor in sirs and/or sepsis
EP3685839A1 (en)	2012-05-14	2020-07-29	Boehringer Ingelheim International GmbH	Linagliptin for use in the treatment of albuminuria and kidney related diseases
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
ES2950384T3 (es)	2014-02-28	2023-10-09	Boehringer Ingelheim Int	Uso médico de un inhibidor de DPP-4
WO2017211979A1 (en)	2016-06-10	2017-12-14	Boehringer Ingelheim International Gmbh	Combinations of linagliptin and metformin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES475573A1 (es) *	1977-07-12	1980-01-16	Fujisawa Pharmaceutical Co	Un procedimiento para preparar nuevos compuestos de cefem
IE65926B1 (en) *	1990-07-19	1995-11-29	Shionogi & Co	Thioalkylthio cephalosporin derivatives

1993
- 1993-07-26 TW TW082105942A patent/TW307769B/zh active
- 1993-07-26 ES ES93305864T patent/ES2115725T3/es not_active Expired - Lifetime
- 1993-07-26 AT AT93305864T patent/ATE165360T1/de not_active IP Right Cessation
- 1993-07-26 EP EP93305864A patent/EP0581552B1/en not_active Expired - Lifetime
- 1993-07-26 DE DE69318077T patent/DE69318077T2/de not_active Expired - Fee Related
- 1993-07-27 UA UA93003172A patent/UA37181C2/uk unknown
- 1993-07-27 US US08/097,205 patent/US5407929A/en not_active Expired - Fee Related
- 1993-07-28 CA CA002101502A patent/CA2101502A1/en not_active Abandoned
- 1993-07-28 IL IL106516A patent/IL106516A/en not_active IP Right Cessation
- 1993-07-28 AU AU44227/93A patent/AU657866B2/en not_active Ceased
- 1993-07-28 HU HU9302194A patent/HU219637B/hu not_active IP Right Cessation
- 1993-07-29 PH PH46601A patent/PH30109A/en unknown
- 1993-07-29 PL PL93299870A patent/PL172835B1/pl unknown
- 1993-07-29 NZ NZ24828593A patent/NZ248285A/en unknown
- 1993-07-29 FI FI933391A patent/FI933391L/fi unknown
- 1993-07-29 PL PL93317972A patent/PL172830B1/pl unknown
- 1993-07-30 ZA ZA935529A patent/ZA935529B/xx unknown
- 1993-07-30 RU RU93047027/04A patent/RU2118959C1/ru not_active IP Right Cessation
- 1993-07-30 BR BR9303235A patent/BR9303235A/pt not_active Application Discontinuation
- 1993-07-30 MX MX9304611A patent/MX9304611A/es unknown
- 1993-07-30 NO NO932745A patent/NO303734B1/no unknown
- 1993-07-30 KR KR1019930014742A patent/KR100245938B1/ko not_active Expired - Fee Related
- 1993-07-31 CN CN93117437A patent/CN1037683C/zh not_active Expired - Fee Related
1998
- 1998-04-23 GR GR980400753T patent/GR3026699T3/el unknown

Also Published As

Publication number	Publication date
PH30109A (en)	1996-12-27
HUT68602A (en)	1995-06-28
MX9304611A (es)	1994-02-28
CN1037683C (zh)	1998-03-11
UA37181C2 (uk)	2001-05-15
IL106516A0 (en)	1993-11-15
GR3026699T3 (en)	1998-07-31
FI933391A0 (fi)	1993-07-29
AU4422793A (en)	1994-02-03
ATE165360T1 (de)	1998-05-15
NZ248285A (en)	1994-07-26
HU9302194D0 (en)	1993-10-28
TW307769B (it)	1997-06-11
FI933391A7 (fi)	1994-02-01
AU657866B2 (en)	1995-03-23
ES2115725T3 (es)	1998-07-01
IL106516A (en)	1998-06-15
EP0581552A3 (en)	1994-06-01
BR9303235A (pt)	1994-03-01
ZA935529B (en)	1994-02-24
NO932745D0 (no)	1993-07-30
DE69318077T2 (de)	1998-10-29
RU2118959C1 (ru)	1998-09-20
EP0581552B1 (en)	1998-04-22
FI933391L (fi)	1994-02-01
CA2101502A1 (en)	1994-02-01
US5407929A (en)	1995-04-18
PL172830B1 (pl)	1997-12-31
KR940005636A (ko)	1994-03-22
NO932745L (no)	1994-02-01
CN1089948A (zh)	1994-07-27
PL172835B1 (pl)	1997-12-31
DE69318077D1 (de)	1998-05-28
KR100245938B1 (ko)	2000-04-01
EP0581552A2 (en)	1994-02-02
PL299870A1 (en)	1994-02-07
HU219637B (hu)	2001-06-28

Publication	Publication Date	Title
NO932745L (no)	1994-02-01	Triazolyltiometyltiocefalosporinhydroklorid, dets krystalliske hydrat samt fremgangsmaate for fremstilling
AU616838B2 (en)	1991-11-07	N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro- 2h-benzopyran or dihydrobenzodioxin)carboxamide derivatives
IL96550A0 (en)	1991-09-16	Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
AU4438489A (en)	1990-10-11	Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
AU2232288A (en)	1989-04-06	Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
AU4236889A (en)	1990-04-12	Imidazoline derivative and preparation thereof
AU7436691A (en)	1991-10-24	Novel 2,9-disubstituted-4H-pyrido(1,2-a)pyrimidin-4-ones
AU3917189A (en)	1990-03-08	Antipsychotic 3-piperazinyl benzazole, benzisoxazole and benzisothiazole derivatives
FI933719A0 (fi)	1993-08-24	4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
HUT53654A (en)	1990-11-28	Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds